Navigation Links
slow in Medical Technology

Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting

... in Chronic Hepatitis C Genotype 1-Infected slow Responders: Final Results of the SUCCESS Study(2) ... therapy in genotype 1-infected patients who have slow response to therapy, defined as having detectable ... randomized, multinational clinical trial, slow responders were randomized at treatment week 36 ...

Eating Walnuts Slows Cancer Growth, Laboratory Study Finds

... /PRNewswire/ -- Snack-sized quantities of walnuts slow cancer growth in mice, reports a Marshall ... always very good to find something that will slow the growth of tumors without being toxic ... in omega-3 fatty acids, which have been shown to slow cancer growth. They also include antioxidants and ...

Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease

... new treatments that might be shown ultimately to slow disease progression. In addition to the biomarker ... that longer term treatment with LY2062430 may slow the clinical progression of Alzheimer's disease, ... secretase inhibitor believed to slow the rate of formation of amyloid beta, ...

Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease

... LY450139 is being tested to see if it can slow the progression associated with Alzheimer's ... modest improvements in symptoms but do not slow the underlying disease process. The IDENTITY ... will represent an advance in the attempt to slow the progression of this fatal disease. ...

NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020

... out during the first second of forced exhalation; slow Vital Capacity (SVC), the amount of air that can ... patients, there are no drugs available that can slow the progressive decline in lung function. NicOx ... out during the first second of forced exhalation; slow Vital Capacity (SVC), the amount of air that can ...

Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease

... this disease early, when medical treatment can slow or halt disease progression, according to the ... patients determine treatment that can potentially slow disease progression. The report is based on ... that early detection and treatment of CKD can slow or prevent the progression of the disease to ...

TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men

... we reach middle age--replacing them with artificial GH, in theory, would slow the aging process. However, there is little evidence to suggest that it is ... with aging and investigates the effects of innovative interventions to slow the aging process and improve health outcomes for older persons. In ...

July 2009 Mayo Clinic Women's HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals

... vitamin C supplements, taken with some other antioxidants and zinc, may slow the progress of age-related macular degeneration. However, there's little ... been well established that adequate vitamin D and calcium can prevent or slow osteoporosis and reduce bone fractures. New research highlights other ...

MADIT-CRT Trial Meets Primary Endpoint

... Landmark trial shows Boston Scientific CRT-Ds slow the progression of heart failure in asymptomatic and mildly symptomatic ... that early intervention with cardiac resynchronization therapy can slow the progression of heart failure. It is the world's largest randomized ...

Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials

... The primary objective of both trials is to test whether solanezumab will slow the cognitive and functional decline of Alzheimer's disease patients as ... trial give us hope that Lilly is on a path toward a treatment that may slow the rate of progression of Alzheimer's disease." EXPEDITION will be ...

Men Treated for Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumption

... Md., April 27 /PRNewswire-USNewswire/ -- Pomegranate juice may slow the progression of post-treatment prostate cancer recurrence, according to ... patients. "This study suggests that pomegranate juice may effectively slow the progression of prostate cancer after unsuccessful treatment," said ...

Astrocytes Help Separate Man From Mouse

... like stroke, Alzheimer's, epilepsy, and spinal cord injury. "Dogma is slow to change, and one of the dogmas of neuroscience is that astrocytes are support cells that don't do much themselves," said Oberheim. "The view is slow to change, but scientists are coming around. Astrocytes are now ...

Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)

... there is only one approved drug for ALS; Riluzole has been demonstrated to slow the progression of this debilitating disease with only modest clinical ... Similar effects on motor nerves and muscles in these patients may slow the progression of ALS by preserving nerve function and improving muscle ...

The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research

... University of Nottingham have made a crucial breakthrough in the battle to slow or prevent the onset of a very common type of dementia and Parkinson's ... takes place. We will use this model to identify targets for new drugs to slow or prevent the disease." Lewy body disease, also known as dementia with ...

Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD

... of earlier treatment, and suggests the possibility that Dimebon may slow of the progression of Alzheimer's. However, open-label extensions are not ... the rate of its removal from the body, these antibody infusions may slow the progression of Alzheimer's. Eric Siemers, MD, Medical Director of ...

First Ever Study on Alzheimer's Disease Treatment in Hispanics Presented at Major Medical Meeting

... communities. "This study reminds us of the value of treating AD to slow symptoms of the disease, and I encourage primary care physicians with ... of the Alzheimer's type. While there is no cure for AD, ARICEPT can help slow the progression of symptoms. Extensive data derived from clinical studies ...

Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies

... have captured the public's attention have focused on molecules that can slow aging and have been narrowly focused on the sirtuin family of genes and ... when humans could molecularly avert the effects of over-eating as well as slow or even reverse the aging process without having to deprive themselves of ...

VIRxSYS to Host a Web Conference to Announce Clinical Trial Update

... ensues. Activation of both cellular and humoral immunity can also halt the slow destruction of the immune system by the latently dormant virus. The ... the massive destruction of CD4 T cells and also halting the subsequent slow destruction of the immune system by HIV. About VIRxSYS VIRxSYS is a ...

Hope for Progeria - Successfully Validated on Mice, a Treatment Could Soon be Tested on Children

... This treatment, combining two existing pharmacological molecules, should slow down the progression of this disease which has hitherto remained ... 25 children affected by progeria in Europe. The aim of this protocol is to slow down the progression of the disease and, if possible, prolong the life ...

Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimer's Therapeutic Antibody

... antibody (passive immunization). Both approaches have the potential to slow or arrest disease progression provided that key safety issues are ... symptoms of the disease, but there are no drugs on the market today that slow or arrest the progression of the disease. These symptomatic drugs are ...

Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat

... the hypothesis that antagonism of the these peripheral CB1 receptors could slow lipogenesis in both adipose tissue and the liver, leading to loss of both ... Council). The main goal of the Laval Hospital Research Center is to slow the obesity epidemic and the progression of cardiovascular and pulmonary ...

Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

... was selection of a treatment based on which drug combination appeared to slow deterioration in the ALS- Functional Score. Results showed that patients ... was treatment selection based on which drug combination appeared to slow deterioration in the ALS-Functional Score. Patients were randomized to ...

Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease

... organization pursuing the discovery and development of drugs to prevent or slow the progression of Huntington disease (HD), announced today that they have ... a biotech approach to rapidly discover and develop drugs that prevent or slow Huntington disease. Through collaborations with academic and industrial ...

Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference

... at physical activity and mental performance as we age. One study found that maintaining or increasing physical activity throughout life may slow cognitive decline as we age. Older adults who were sedentary throughout the study had the lowest levels of cognitive function at the beginning and ...

Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline

... to increase brain DHA levels, based on a measured increase of DHA in study participants' cerebrospinal fluid (CSF). However, DHA treatment did not slow the rate of change on tests of mental function (ADAS-cog), global dementia severity status (CDR-SOB), activities of daily living (ADL), or behavioral ...

MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease

... 12 people with recently diagnosed PD to determine if the drug can increase DJ-1 levels and set the stage for determining whether phenylbutyrate may slow disease progression. Richard Smeyne, PhD, of Saint Jude Children's Research Hospital will test the hypothesis that the virulent H5N1 ("bird ...

Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer

... severe gastrointestinal toxicity. It is likely that this is due to the selective accumulation of paclitaxel poliglumex in tumor tissue with continual slow release of the active agent, paclitaxel," noted Jack Singer, M.D., Chief Medical Officer at CTI. CTI plans to explore with the U.S. Food and ...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

... study comparing XERECEPT(R) to dexamethasone for the control of acute symptoms associated with peritumoral edema, was discontinued due to slow enrollment. The study results from the 37 patients who enrolled show that XERECEPT(R) was as effective as 4mg/day of dexamethasone in the treatment ...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

... identified in clinical studies include nausea, abdominal pain, gas, constipation, vomiting, pain on injection, high or low blood sugar levels and slow or irregular heart rate. Many patients developed gallstones, although few patients required treatment. For full prescribing information, please ...

Mayo Researchers Help Discover Genetic Cause for Primary Biliary Cirrhosis

... Lazaridis, M.D. , a Mayo Clinic hepatologist and a senior researcher in the study. Currently, treatments for primary biliary cirrhosis can slow progression of the disease, which affects 1 in 2,500 Americans, 90 percent of them women. However, about half of patients do not respond to medical ...

Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease

... of Dimebon in AD. "Due to the complexity of Alzheimer's disease, the condition often requires combination treatment to help relieve symptoms and slow disease progression," said Bengt Winblad, professor of geriatrics, Karolinska Institute . "The CONCERT trial will explore the potential additive ...

CRESTOR(R) Reduced CV Risk in Patients Achieving Low LDL and hsCRP Targets in New JUPITER Analysis

... levels and to increase HDL-C in adult patients with primary hyperlipidemia and mixed dyslipidemia. CRESTOR is also indicated as an adjunct to diet to slow the progression of atherosclerosis as part of a treatment strategy to lower Total-C and LDL-C to target levels. CRESTOR is not approved to prevent ...

CRESTOR(R) Reduced Risk of Blood Clots in the Veins

... levels and to increase HDL-C in adult patients with primary hyperlipidemia and mixed dyslipidemia. CRESTOR is also indicated as an adjunct to diet to slow the progression of atherosclerosis as part of a treatment strategy to lower Total-C and LDL-C to target levels. CRESTOR is not approved to prevent ...

MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer

... is a targeted therapy designed to interfere with a tumor's ability to generate new blood vessels. However, Sorafenib has been shown to only slow liver cancer from progressing for a few months longer when compared to no treatment. The cooperative research and development agreement with ...

Leader in Prostate Health Urges Prostate Cancer Screening in Face of Contradicting Data

... 10 years. "For all we know, additional data from the trial may show a mortality benefit with screening. As prostate cancer, in general, is a slow growing disease, in the future the data may conclude that there is a benefit to prostate cancer screening," continued Poage. Both studies are ...

Teva's Azilect Use Dramatically Increases in Second-Line Therapy for the Treatment of Parkinson's Disease

... in the specialist setting as 55 percent of surveyed neurologists believe that the A Randomized Placebo Controlled Study to Show That Rasagiline May slow Disease Progression for Parkinson's Disease (ADAGIO) trial results demonstrated Azilect has a disease-modifying effect and will increase their ...

Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)

... population ages. Currently marketed drugs transiently affect some of the symptoms of the disease, but there are no drugs on the market today that slow or arrest the progression of the disease. These symptomatic drugs are projected to generate more than US $6 billion in sales by 2010, indicating both ...

ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease

... limited over time, after which the evolution of the degenerative process starts progressing again. EHT 0202 is an interesting approach to potentially slow the evolution of the disease." The Phase IIa trial is a multicenter, randomized, double-blind, placebo-controlled study primarily ...

Parkinson's Disease Foundation Awards $300,000 in Bridge Funding for Innovative Research Projects

... the protein clumping and will examine the most promising candidates for their potential to not only treat Parkinson's, but also to theoretically slow its progression. Dr. Sulzer will investigate the role that inflammation, caused by an immune response, plays in causing the death of neurons in ...

New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation

... with AF are related to managing the arrhythmia itself and to the prevention of thromboembolism. AF may be treated with medications that either slow the heart rate or revert the heart rhythm back to normal sinus rhythm. About dronedarone (Multaq (R) ) Multaq(R) (dronedarone) is an ...
Other Contents
(Date:7/24/2014)... Bhavani Iyer, O.D., a low vision specialist at The ... Medical School, has been awarded a grant to help ... with eyeglasses, medication or surgery. , Even with corrective ... at best. However, there are a variety of low ... to help offset their vision loss. , Iyer is ...
(Date:7/24/2014)... this week for an all-day public forum on a ... (EPA) to dredge toxic sediment from an eight-mile stretch ... called the plan, which proposes removing 4.3 million cubic ... riverbed, one of the largest cleanups in the agency,s ... off-site. , "We need to ensure the future well-being ...
(Date:7/24/2014)... hazard in the United States, wildland managers often utilize ... suppressed trees (ladder fuels). These cuttings and other ... fire danger in order to dispose of the material. ... managers often cover all or part of the debris ... agricultural plastic, in order to keep water out. A ...
Breaking Biology News(10 mins):UTHealth Dr. Bhavani Iyer awarded low vision grant 2Experts Weigh the Pros and Cons of a $1.7 Billion EPA Cleanup Plan for the Passaic River at an NJIT 2Study gives new perspective on agricultural plastic, debris burning, and air quality 2
(Date:7/25/2014)... older adults on five continents found that nearly 1 ... simple test that measures how fast people walk and ... for pre-dementia were twice as likely as others to ... scientists at Albert Einstein College of Medicine ... was published online on July 16, 2014 in ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Hastings and ... offering discount attorney’s fees with regard to personal injury ... provide a wide range of legal services for those ... negligence of another individual or corporation. Free initial consultation ... the validity of a potential personal injury claim ...
(Date:7/25/2014)... 2014 As thousands of transvaginal mesh ... Bernstein Liebhard LLP notes that the Food & Drug ... advocacy group, Public Citizen, to order a global recall ... May 1, 2014, and released to the public last ... a ban on the marketing of all surgical mesh ...
(Date:7/25/2014)... FRIDAY, July 25, 2014 (HealthDay News) -- Babies seem ... suggests. By the time women are 34 weeks ... of their mother,s voice reciting a familiar nursery rhyme, ... predominant source of sensory stimulation in the developing fetus," ... University of Florida,s College of Nursing, said in a ...
(Date:7/25/2014)... vulnerable neurons and reduce motor deficits in a ... University School of Medicine have shown. , The ... Parkinson,s Disease . , The findings demonstrate that ... at sufficient levels and have beneficial effects when ... Previous studies of XPro1595 in animals tested more ...
Breaking Medicine News(10 mins):Health News:Slow walking speed and memory complaints can predict dementia 2Health News:Slow walking speed and memory complaints can predict dementia 3Health News:Slow walking speed and memory complaints can predict dementia 4Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 4Health News:Rhymes Reveal Evidence of Learning in the Womb 2Health News:Anti-inflammatory drug can prevent neuron loss in Parkinson's model 2
Other TagsOther Tags